Shares of TASER International (NASDAQ: TASR) are trading lower today as investors react to the company's second-quarter earnings report. The stun-gun issue reported a narrowed quarterly loss of $723,403, or a penny per share, compared to its year-ago loss of 3 cents per share.
Revenue for the period increased 3.5% to $21.8 million, though gross margin fell to 62.9% from 64.5%. Research and development expenses jumped 45% during the quarter as TASER poured more cash into new products, including its recently launched X3 device.
The second-quarter figures exceeded analysts' expectations, according to a survey by Thomson Reuters. The consensus estimate called for a deeper loss of 4 cents per share on just $19.13 million in revenue.
Unfortunately, the better-than-expected results haven't translated to any strength today in TASER shares. The stock was off more than 4% at its intraday nadir, and continues to wallow in negative territory.
From a technical perspective, though, the equity's prospects aren't too dim. TASER is currently poised to finish July above its 10-month moving average, which would mark the first monthly breach of this resistance level since December 2007. Additionally, the stock's pullback has so far been contained by new-found support at its 10-day trendline.
The security could pare some of its post-earnings losses if short sellers are prompted to take profits. Short interest on the shares jumped by 9% during the past month, and now accounts for 5.5% of TASR's available float. Should these bears decide to hit the exits, it would take seven days, at the stock's average daily trading volume, for all of these shorted shares to be covered.
Elizabeth Harrow is an analyst and financial writer in the research department at Schaeffer's Investment Research. She is featured in the video series Schaeffer's Daily Q&A on SchaeffersResearch.com.
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

